Melioidosis and glanders

References

Reference articles

1. Centers for Disease Control and Prevention. Melioidosis. January 2012 [internet publication].Full text

2. Nierman WC, DeShazer D, Kim HS, et al. Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci USA. 2004;101:14246-14251.Full text  Abstract

3. rinivasan A, Kraus CN, DeShazer D, et al. Glanders in a military research microbiologist. N Engl J Med. 2001;345:256-258.Full text  Abstract

4. Dance DAB. Melioidosis and glanders as possible biological weapons. In: Fong I, Alibek K, eds. Bioterrorism and infectious agents: a new dilemma for the 21st century. New York, NY: Springer; 2005:99-145.

5. Federal Select Agent Program. Select agents and toxins list. 2017 [internet publication].Full text

6. Punyagupta S. Review of 686 cases and presentation of a new clinical classification. In: Punyagupta S, Sirisanthana T, Stapatayavong B, eds. Melioidosis. Bangkok: Bangkok Medical Publisher; 1989:217-229.

7. Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010;4:e900.Full text  Abstract

8. Currie BJ. Melioidosis: evolving concepts in epidemiology, pathogenesis and treatment. Semin Respir Crit Care Med. 2015;36:111-125.Full text  Abstract

9. Gibney KB, Cheng AC, Currie BJ. Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin Infect Dis. 2008;47:603-609.Full text  Abstract

10. McLeod C, Morris PS, Bauert PA, et al. Clinical presentation and medical management of melioidosis in children: a 24-year prospective study in the Northern Territory of Australia and review of the literature. Clin Infect Dis. 2015;60:21-26.Full text  Abstract

11. Pagnarith Y, Kumar V, Thaipadungpanit J, et al. Emergence of pediatric melioidosis in Siem Reap, Cambodia. Am J Trop Med Hyg. 2010;82:1106-1112.Full text  Abstract

12. Dance DA, Davis TM, Wattanagoon Y, et al. Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis. 1989;159:654-660. Abstract

13. Morse LP, Smith J, Mehta J, et al. Osteomyelitis and septic arthritis from infection with Burkholderia pseudomallei: a 20-year prospective melioidosis study from northern Australia. J Orthop. 2013;10:86-91.Full text  Abstract

14. Garg R, Shaw T, Bhat SN, et al. Melioidosis: the great mimicker presenting as spondylodiscitis. BMJ Case Rep. 2018 Feb 8;2018. pii: bcr-2017-223223. Abstract

15. Prasad GL. Cranial Melioidosis Presenting as Osteomyelitis and/or Extra-Axial Abscess: Literature Review. World Neurosurg. 2020 Feb;134:67-75.Full text  Abstract

16. Prabhat V, Gantaguru A, Behera S, et al. Spinal Epidural Abscess in Melioidosis: A Rare Case Report from Eastern India. Cureus. 2019 Mar 6;11(3):e4187.Full text  Abstract

17. Koszyca B, Currie BJ, Blumbergs PC. The neuropathology of melioidosis: two cases and a review of the literature. Clin Neuropathol. 2004;23:195-203. Abstract

18. Currie BJ, Fisher DA, Howard DM, et al. Neurological melioidosis. Acta Trop. 2000;74:145-151. Abstract

19. Wongwandee M, Linasmita P. Central nervous system melioidosis: A systematic review of individual participant data of case reports and case series. PLoS Negl Trop Dis. 2019 Apr;13(4):e0007320.Full text  Abstract

20. Chadwick DR, Ang B, Sitoh YY, et al. Cerebral melioidosis in Singapore: a review of five cases. Trans R Soc Trop Med Hyg. 2002;96:72-76. Abstract

21. Bodilsen J, Vammen S, Fuursted K, et al. Mycotic aneurysm caused by Burkholderia pseudomallei in a previously healthy returning traveller. BMJ Case Rep. 2014;2014.Full text  Abstract

22. Chakravorty A, Heath CH. Melioidosis: An updated review. Aust J Gen Pract. 2019 May;48(5):327-332.Full text  Abstract

23. Birnie E, Virk HS, Savelkoel J, et al. Global burden of melioidosis in 2015: a systematic review and data synthesis. Lancet Infect Dis. 2019 Aug;19(8):892-902.Full text  Abstract

24. Currie BJ, Dance DA, Cheng AC. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans R Soc Trop Med Hyg. 2008;102(suppl 1):S1-S4. Abstract

25. Limmathurotsakul D, Golding N, Dance DA, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 2016;1:15008. Abstract

26. Saïdani N, Griffiths K, Million M, et al. Melioidosis as a travel-associated infection: case report and review of the literature. Travel Med Infect Dis. 2015;13:367-381. Abstract

27. Donahue MA, Newcomb G, Spinella S, et al. CNS Melioidosis in a Traveler Returning from Cabo, Mexico. Open Forum Infect Dis. 2019 Feb;6(2):ofz005.Full text  Abstract

28. Yuan Y, Yao Z, Xiao E, et al. The first imported case of melioidosis in a patient in central China. Emerg Microbes Infect. 2019;8(1):1223-1228.Full text  Abstract

29. Alwarthan SM, Aldajani AA, Al Zahrani IM, et al. Melioidosis: Can Tropical Infections Present in Nonendemic Areas? A Case Report and Review of the Literature. Saudi J Med Med Sci. 2018 May-Aug;6(2):108-111.Full text  Abstract

30. Birnie E, Savelkoel J, Reubsaet F, et al. Melioidosis in travelers: An analysis of Dutch melioidosis registry data 1985-2018. Travel Med Infect Dis. 2019 Jul 29;:101461.Full text  Abstract

31. Centers for Disease Control and Prevention. Statement on melioidosis cases. August 2021 [internet publication].Full text

32. Suputtamongkol Y, Hall AJ, Dance DA, et al. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol. 1994;23:1082-1090. Abstract

33. Centers for Disease Control and Prevention. Glanders. October 2017 [internet publication].Full text

34. Podin Y, Sarovich DS, Price EP, et al. Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides. Antimicrob Agents Chemother. 2014;58:162-166.Full text  Abstract

35. Currie BJ, Jacups SP. Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis. 2003;9:1538-1542.Full text  Abstract

36. Cheng AC, Jacups SP, Gal D, et al. Extreme weather events and environmental contamination are associated with case-clusters of melioidosis in the Northern Territory of Australia. Int J Epidemiol. 2006;35:323-329.Full text  Abstract

37. Limmathurotsakul D, Wongsuvan G, Aanensen D, et al. Melioidosis caused by Burkholderia pseudomallei in drinking water, Thailand, 2012. Emerg Infect Dis. 2014;20:265-268.Full text  Abstract

38. Goshorn RK. Recrudescent pulmonary melioidosis. A case report involving the so-called 'Vietnamese time bomb'. Indiana Med. 1987;80:247-249. Abstract

39. Van Zandt KE, Greer MT, Gelhaus HC. Glanders: an overview of infection in humans. Orphanet J Rare Dis. 2013;8:131.Full text  Abstract

40. Chow TK, Eu LC, Chin KF, et al. Incidental splenic granuloma due to Burkholderia pseudomallei: a case of asymptomatic latent melioidosis? Am J Trop Med Hyg. 2016;94:522-524. Abstract

41. Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med. 2012;367:1035-1044. Abstract

42. Lo TJ, Ang LW, James L, et al. Melioidosis in a tropical city state, Singapore. Emerg Infect Dis. 2009;15:1645-1647.Full text  Abstract

43. Limmathurotsakul D, Kanoksil M, Wuthiekanun V, et al. Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study. PLoS Negl Trop Dis. 2013;7:e2072.Full text  Abstract

44. Ko WC, Cheung BM, Tang HJ, et al. Melioidosis outbreak after typhoon, southern Taiwan. Emerg Infect Dis. 2007;13:896-898.Full text  Abstract

45. Currie BJ, Price EP, Mayo M, et al. Use of whole-genome sequencing to link Burkholderia pseudomallei from air sampling to mediastinal melioidosis, Australia. Emerg Infect Dis. 2015;21:2052-2054.Full text  Abstract

46. Amadasi S, Dal Zoppo S, Bonomini A, et al. A case of melioidosis probably acquired by inhalation of dusts during a helicopter flight in a healthy traveler returning from Singapore. J Travel Med. 2015;22:57-60.Full text  Abstract

47. Guendel I, Ekpo LL, Hinkle MK, et al. Melioidosis after Hurricanes Irma and Maria, St. Thomas/St. John District, US Virgin Islands, October 2017. Emerg Infect Dis. 2019 Oct;25(10):1952-1955.Full text  Abstract

48. Suputtamongkol Y, Chaowagul W, Chetchotisakd P, et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis. 1999;29:408-413.Full text  Abstract

49. Limmathurotsakul D, Chaowagul W, Chierakul W, et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis. 2006;43:979-986.Full text  Abstract

50. Commons RJ, Grivas R, Currie BJ. Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis. Intern Med J. 2014;44:1245-1246. Abstract

51. Fong SM, Wong KJ, Fukushima M, et al. Thalassemia major is a major risk factor for pediatric melioidosis in Kota Kinabalu, Sabah, Malaysia. Clin Infect Dis. 2015;60:1802-1807.Full text  Abstract

52. Geake JB, Reid DW, Currie BJ, et al. An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis. BMC Pulm Med. 2015;15:116.Full text  Abstract

53. Johnson MM, Ainslie KM. Vaccines for the prevention of melioidosis and glanders. Curr Trop Med Rep. 2017 Sep;4(3):136-145. Abstract

54. Peacock SJ, Schweizer HP, Dance DA, et al. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis. 2008;14:e2.Full text  Abstract

55. Lipsitz R, Garges S, Aurigemma R, et al. Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei infection, 2010. Emerg Infect Dis. 2012;18:e2.Full text  Abstract

56. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005;18:383-416.Full text  Abstract

57. Sarovich DS, Garin B, De Smet B, et al. Phylogenomic analysis reveals an Asian origin for African burkholderia pseudomallei and further supports melioidosis endemicity in Africa. mSphere. 2016;1:e00089-15.Full text  Abstract

58. Dance DA. Editorial commentary: melioidosis in Puerto Rico: the iceberg slowly emerges. Clin Infect Dis. 2015;60:251-253.Full text  Abstract

59. Dance DA. Melioidosis: the tip of the iceberg? Clin Microbiol Rev. 1991;4:52-60.Full text  Abstract

60. Sapian M, Khair MT, How SH, et al. Outbreak of melioidosis and leptospirosis co-infection following a rescue operation. Med J Malaysia. 2012;67:293-297.Full text  Abstract

61. Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis. 2000;31:981-986.Full text  Abstract

62. Meumann EM, Cheng AC, Ward L, et al. Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis. 2012;54:362-369.Full text  Abstract

63. Stephens DP, Thomas JH, Ward LM, et al. Melioidosis causing critical illness: a review of 24 years experience from the Royal Darwin Hospital ICU. Crit Care Med. 2016;44:1500-1505. Abstract

64. Wuthiekanun V, Suputtamongkol Y, Simpson AJ, et al. Value of throat swab in diagnosis of melioidosis. J Clin Microbiol. 2001;39:3801-3802.Full text  Abstract

65. Wuthiekanun V, Dance DA, Wattanagoon Y, et al. The use of selective media for the isolation of Pseudomonas pseudomallei in clinical practice. J Med Microbiol. 1990;33:121-126. Abstract

66. Peacock SJ, Chieng G, Cheng AC, et al. Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol. 2005;43:5359-5361.Full text  Abstract

67. Limmathurotsakul D, Wuthiekanun V, Chierakul W, et al. Role and significance of quantitative urine cultures in diagnosis of melioidosis. J Clin Microbiol. 2005;43:2274-2276.Full text  Abstract

68. Hoffmaster AR, AuCoin D, Baccam P, et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis. 2015;21:e141045.Full text  Abstract

69. Wibulpolprasert B, Dhiensiri T. Visceral organ abscesses in melioidosis: sonographic findings. J Clin Ultrasound. 1999;27:29-34. Abstract

70. Lim KS, Chong VH. Radiological manifestations of melioidosis. Clin Radiol. 2010;65:66-72. Abstract

71. Dhiensiri T, Puapairoj S, Susaengrat W. Pulmonary melioidosis: clinical-radiologic correlation in 183 cases in northeastern Thailand. Radiology. 1988;166:711-715. Abstract

72. Wuthiekanun V, Chierakul W, Langa S, et al. Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg. 2006;74:1074-1075.Full text  Abstract

73. Kaestli M, Richardson LJ, Colman RE, et al. Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens. J Clin Microbiol. 2012;50:2059-2062.Full text  Abstract

74. Robertson G, Sorenson A, Govan B, et al. Rapid diagnostics for melioidosis: a comparative study of a novel lateral flow antigen detection assay. J Med Microbiol. 2015;64:845-848. Abstract

75. Houghton RL, Reed DE, Hubbard MA, et al. Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis. PLoS Negl Trop Dis. 2014;8:e2727.Full text  Abstract

76. Rizzi MC, Rattanavong S, Bouthasavong L, et al. Evaluation of the Active Melioidosis Detect™ test as a point-of-care tool for the early diagnosis of melioidosis: a comparison with culture in Laos. Trans R Soc Trop Med Hyg. 2019 Dec 1;113(12):757-763.Full text  Abstract

77. Chaowagul W, White NJ, Dance DA, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis. 1989;159:890-899. Abstract

78. St John JA, Ekberg JA, Dando SJ, et al. Burkholderia pseudomallei penetrates the brain via destruction of the olfactory and trigeminal nerves: implications for the pathogenesis of neurological melioidosis. MBio. 2014;5:e00025.Full text  Abstract

79. Morse LP, Moller CC, Harvey E, et al. Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective melioidosis study. J Urol. 2009;182:542-547. Abstract

80. Cheng AC, Currie BJ, Dance DA, et al. Clinical definitions of melioidosis. Am J Trop Med Hyg. 2013;88:411-413.Full text  Abstract

81. Centers for Disease Control and Prevention. Glanders: healthcare response activities. Oct 2017 [internet publication].Full text

82. Pitman MC, Luck T, Marshall CS, et al. Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigm. PloS Negl Trop Dis. 2015;9:e0003586.Full text  Abstract

83. Dance D. Treatment and prophylaxis of melioidosis. Int J Antimicrob Agents. 2014;43:310-318.Full text  Abstract

84. Chierakul W, Anunnatsiri S, Short JM, et al. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis. 2005;41:1105-1113.Full text  Abstract

85. Dance DA, Davong V, Soeng S, et al. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei. Int J Antimicrob Agents. 2014;44:368-369.Full text  Abstract

86. Chetchotisakd P, Chierakul W, Chaowagul W, et al. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet. 2014;383:807-814.Full text  Abstract

87. Cheng AC, McBryde ES, Wuthiekanun V, et al. Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis. Antimicrob Agents Chemother. 2009;53:4193-4199.Full text  Abstract

88. Sullivan RP, Ward L, Currie BJ. Oral eradication therapy for melioidosis: Important but not without risks. Int J Infect Dis. 2019 Mar;80:111-114.Full text  Abstract

89. Cheng AC, Chierakul W, Chaowagul W, et al. Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis. Am J Trop Med Hyg. 2008;78:208-209.Full text  Abstract

90. Cheng AC, Limmathurotsakul D, Chierakul W, et al. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis. 2007;45:308-314.Full text  Abstract

91. Cheng AC, Fisher DA, Anstey NM, et al. Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother. 2004;48:1763-1765.Full text  Abstract

92. Tapia D, Sanchez-Villamil JI, Torres AG. Emerging role of biologics for the treatment of melioidosis and glanders. Expert Opin Biol Ther. 2019 Dec;19(12):1319-1332.Full text  Abstract

93. Shearer JD, Saylor ML, Butler CM, et al. GC-072: A Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens. Antimicrob Agents Chemother. 2019 Sep 23;:.Full text  Abstract

94. Subramony H, Gunasekaran S, Paul Pandi VK. Disseminated melioidosis with native valve endocarditis: a case report. Eur Heart J Case Rep. 2019 Jun 1;3(2):.Full text  Abstract

95. Sia T, Podin Y, Chuah TB, et al. Melioidosis: an unusual cause of infective endocarditis: a case report. Eur Heart J Case Rep. 2018 Jun;2(2):yty055.Full text  Abstract

Use of this content is subject to our disclaimer